I don’t have real-time access to the latest headlines right this moment. Based on recent recall activity around Ramipril, there have been multiple nationwide recalls in late 2024 and into 2025 related to manufacturing or ingredient sourcing issues, with FDA/ MHRA updates advising patients to check batch numbers and talk to their healthcare providers. For the most current news, please check trusted sources like the FDA’s recall notices, the UK MHRA, and major outlets.
What I can provide right now:
- How to check if your Ramipril is affected
- What to do if your medication is part of a recall
- Where to find authoritative, up-to-date recall notices
If you’d like, I can guide you step-by-step to verify your specific lot/batch, outline the steps to contact your pharmacist or prescriber, and summarize the official recall notices from the FDA and MHRA. I can also help you set up a quick alert so you’re notified as soon as new information becomes available. Would you like me to outline those steps?
Sources
Batch affected GR174091
cpsc.org.ukThe Food and Drug Administration has recalled more than 110,000 bottles of blood pressure medication after it was found that a key ingredient in the drugs was compromised.
www.audacy.comOver 600,000 bottles of Ramipril blood pressure medication recalled due to manufacturing issues. Patient safety prioritized.
theheartysoul.comHealth officials have issued an urgent recall for a batch of the common blood pressure medication Ramipril, after discovering a manufacturing error resulted in some capsules containing a different medication, Amlodipine, instead. While both drugs are used to treat high blood pressure, the accidental substitution could lead to side effects like dizziness from lower than normal blood pressure in some patients.
nationaltoday.comSeveral high blood pressure drugs have been recalled the past 3 years due to an “unexpected” impurity.
www.healthline.comramipril capsules recall Latest Breaking News, Pictures, Videos, and Special Reports from The Economic Times. ramipril capsules recall Blogs, Comments and Archive News on Economictimes.com
economictimes.indiatimes.comThe MHRA has advised pharmacy and healthcare professionals to stop supplying the impacted batch and return all remaining stock to their suppliers.
www.gov.ukAnyone in possession of the affected batches is being urged to return the medication to their local pharmacy
www.gbnews.com